EDSA
Price
$3.40
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
XBIO
Price
$3.92
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
Ad is loading...

EDSA vs XBIO

Header iconEDSA vs XBIO Comparison
Open Charts EDSA vs XBIOBanner chart's image
Edesa Biotech
Price$3.40
Change-$0.00 (-0.00%)
Volume$2.33K
CapitalizationN/A
Xenetic Biosciences
Price$3.92
Change-$0.00 (-0.00%)
Volume$4.93K
CapitalizationN/A
View a ticker or compare two or three
EDSA vs XBIO Comparison Chart
Loading...
EDSA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
EDSA vs. XBIO commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDSA is a Buy and XBIO is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (EDSA: $3.40 vs. XBIO: $3.92)
Brand notoriety: EDSA and XBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDSA: 23% vs. XBIO: 38%
Market capitalization -- EDSA: $13.93M vs. XBIO: $6.66M
EDSA [@Biotechnology] is valued at $13.93M. XBIO’s [@Biotechnology] market capitalization is $6.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDSA’s FA Score shows that 0 FA rating(s) are green whileXBIO’s FA Score has 1 green FA rating(s).

  • EDSA’s FA Score: 0 green, 5 red.
  • XBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, XBIO is a better buy in the long-term than EDSA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDSA’s TA Score shows that 4 TA indicator(s) are bullish.

  • EDSA’s TA Score: 4 bullish, 5 bearish.

Price Growth

EDSA (@Biotechnology) experienced а -11.08% price change this week, while XBIO (@Biotechnology) price change was +4.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

EDSA is expected to report earnings on Dec 13, 2023.

XBIO is expected to report earnings on Aug 11, 2023.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDSA($13.9M) has a higher market cap than XBIO($6.66M). XBIO YTD gains are higher at: 13.620 vs. EDSA (-25.602). XBIO has higher annual earnings (EBITDA): -5.01M vs. EDSA (-6.95M). XBIO has more cash in the bank: 7.3M vs. EDSA (2.04M). EDSA has less debt than XBIO: EDSA (38.8K) vs XBIO (153K). XBIO has higher revenues than EDSA: XBIO (2.52M) vs EDSA (0).
EDSAXBIOEDSA / XBIO
Capitalization13.9M6.66M209%
EBITDA-6.95M-5.01M139%
Gain YTD-25.60213.620-188%
P/E RatioN/AN/A-
Revenue02.52M-
Total Cash2.04M7.3M28%
Total Debt38.8K153K25%
FUNDAMENTALS RATINGS
EDSA vs XBIO: Fundamental Ratings
EDSA
XBIO
OUTLOOK RATING
1..100
5380
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
6559
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XBIO's Valuation (19) in the Biotechnology industry is significantly better than the same rating for EDSA (98) in the null industry. This means that XBIO’s stock grew significantly faster than EDSA’s over the last 12 months.

XBIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as EDSA (100) in the null industry. This means that XBIO’s stock grew similarly to EDSA’s over the last 12 months.

XBIO's SMR Rating (96) in the Biotechnology industry is in the same range as EDSA (98) in the null industry. This means that XBIO’s stock grew similarly to EDSA’s over the last 12 months.

XBIO's Price Growth Rating (59) in the Biotechnology industry is in the same range as EDSA (65) in the null industry. This means that XBIO’s stock grew similarly to EDSA’s over the last 12 months.

XBIO's P/E Growth Rating (100) in the Biotechnology industry is in the same range as EDSA (100) in the null industry. This means that XBIO’s stock grew similarly to EDSA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDSA
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 28 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
EDSA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

EDSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDSA has been loosely correlated with HRTX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if EDSA jumps, then HRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDSA
1D Price
Change %
EDSA100%
N/A
HRTX - EDSA
34%
Loosely correlated
+3.24%
SNPX - EDSA
33%
Poorly correlated
+4.51%
IPSC - EDSA
33%
Poorly correlated
+0.72%
ORMP - EDSA
32%
Poorly correlated
-1.90%
LXRX - EDSA
32%
Poorly correlated
+3.89%
More

XBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, XBIO has been loosely correlated with SYRE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIO jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIO
1D Price
Change %
XBIO100%
+3.29%
SYRE - XBIO
34%
Loosely correlated
-1.18%
VXRT - XBIO
29%
Poorly correlated
+1.43%
EDSA - XBIO
29%
Poorly correlated
N/A
CDTX - XBIO
28%
Poorly correlated
-1.03%
AUTL - XBIO
27%
Poorly correlated
+2.48%
More